SynAct Pharma AB (STO:SYNACT)
18.94
-0.16 (-0.84%)
Aug 14, 2025, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 999.43 million as of August 14, 2025. Its market cap has increased by 185.06% in one year.
Market Cap
999.43M
Enterprise Value
949.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
18.94
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 999.43M, an increase of 1,467.68%. That is a compound annual growth rate of 35.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 999.43M | 139.81% |
Dec 30, 2024 | 416.76M | 32.69% |
Dec 29, 2023 | 314.09M | -87.00% |
Dec 30, 2022 | 2.42B | -34.75% |
Dec 30, 2021 | 3.70B | 242.52% |
Dec 30, 2020 | 1.08B | 809.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 94.77B |
Sectra AB | 67.02B |
Getinge AB | 54.41B |
Medicover AB | 41.07B |
Asker Healthcare Group AB | 38.30B |
Camurus AB | 37.76B |
Bonesupport Holding AB | 20.15B |
AddLife AB | 19.96B |